Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma

被引：6
|
作者：
Wang, Xiaoli [1 ]
Wu, Jingjing [1 ]
Zhang, Mingzhi [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Zhengzhou, Henan, Peoples R China
来源：
HEMATOLOGY | 2019年 / 24卷 / 01期
关键词：
Anaplastic large cell lymphoma; anaplastic lymphoma kinase; treatment; prognosis; PIVOTAL PHASE-II; BRENTUXIMAB VEDOTIN; OPEN-LABEL; ALK; DISEASE; TRANSPLANTATION; MULTICENTER; DOXORUBICIN; ADULTS; ERA;
D O I：
10.1080/16078454.2019.1613290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anaplastic lymphoma kinase negative anaplastic large cell lymphoma (ALK- ALCL) is a definite entity in the WHO 2016 Classification that represents 2-3% of non-Hodgkin lymphoma (NHL) and 12% of T-cell NHL cases. ALK- ALCL lacks ALK protein expression, but expresses CD30 and has morphologic features similar to ALK positive anaplastic large cell lymphoma (ALK+ ALCL). Some studies indicate that ALK- ALCL and ALK+ ALCL possess different molecular and genetic characteristics. Besides, ALK- ALCL is worse than ALK+ ALCL in terms of treatment outcome, prognosis, and long-term survival. This review is aimed at summarizing information about ALK- ALCL, especially with respect to the treatment and prognosis.
引用
收藏
页码：440 / 445
页数：6
相关论文
共 50 条
  • [1] Anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
    Kote, Shraddha
    Chopkar, Samruddhi
    Supekar, Bhagyashree
    Mukhi, Jayesh
    EGYPTIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 44 (02): : 115 - 119
  • [2] Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement
    Khanlari, Mahsa
    Tang, Guilin
    Hao, Suyang
    Gong, Yun
    Li, Shaoying
    Miranda, Roberto N.
    Lin, Pei
    Iyer, Swaminathan
    Yin, Cameron C.
    Xie, Wei
    Vega, Francisco
    Medeiros, L. J.
    Xu, Jie
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : E17 - E21
  • [3] Diagnosis of anaplastic lymphoma kinase-negative anaplastic large cell lymphoma on pleural fluid cytology
    Greenland, Nancy Y.
    Lu, Chuanyi M.
    Cook, Stephen
    Peng, Yue
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (12) : E458 - E461
  • [4] Update on the Treatment of Anaplastic Large Cell Lymphoma
    Khoan Vu
    Ai, Weiyun
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (02) : 135 - 141
  • [5] A Giant Anaplastic Lymphoma Kinase Positive Anaplastic Large Cell Lymphoma: Case Report
    Dai, Xi
    Ma, Jing
    Ming, Cheng
    Gao, Yingqin
    Lou, Fan
    Zhang, Tiesong
    He, Qingjun
    CLINICAL LABORATORY, 2023, 69 (09) : 1999 - 2003
  • [6] Anaplastic lymphoma kinase positive anaplastic large cell Lymphoma presenting as retroperitoneal fibrosis
    Hammer, Suntrea T. G.
    Jentzen, Jeffrey M.
    Lim, Megan S.
    HUMAN PATHOLOGY, 2011, 42 (11) : 1810 - 1812
  • [7] Acute leukemic phase of anaplastic lymphoma kinase-anaplastic large cell lymphoma: A case report and review of the literature
    Zhang, Huai-Feng
    Guo, Yan
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (21) : 5439 - 5445
  • [8] Management of Anaplastic Large Cell Lymphoma
    Chihara, Dai
    Fanale, Michelle A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (02) : 209 - +
  • [9] Anaplastic large cell lymphoma, ALK-negative
    Ferreri, Andres J. M.
    Govi, Silvia
    Pileri, Stefano A.
    Savage, Kerry J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (02) : 206 - 215
  • [10] Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma masquerading as Behcet's disease: A case report and review of literature
    Luo, Juan
    Jiang, Ying-Han
    Lei, Zi
    Miao, Ying-Lei
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (20) : 3377 - 3383
12345